International Conference on Molecular Imaging and Theranostics in Prostate Cancer

The European Association of Nuclear Medicine (EANM), the society for nuclear medicine, molecular imaging and theranostics, is announcing the EANM Focus Meeting – an annual conference in a new format. The Meeting will take place in the first months of each year. It will supplement the EANM Annual Congress in October and the educational events organised by EANM/ESMIT.

The first EANM Focus Meeting will be on molecular imaging and theranostics in prostate cancer. Oncologists, urologists, imagers, clinical and basic scientists and patient-advocates will lecture and participate in the discussions. It will provide an in-depth overview of the current state of the art and future directions in the management of prostate cancer, with a focus on the role of imaging in general and nuclear medicine in particular, now and in the future.

Based on the conference’s results, a consensus statement will be produced. As the lectures and discussions will be at an advanced level and do not aim to provide basic overviews and education, the meeting will be particularly advantageous to clinicians who are already engaged in the diagnosis and treatment of prostate cancer.